173 related articles for article (PubMed ID: 33841579)
1. Antiaging gene Klotho regulates epithelial-mesenchymal transition and increases sensitivity to pemetrexed by inducing lipocalin-2 expression.
Takegahara K; Usuda J; Inoue T; Sonokawa T; Matsui T; Matsumoto M
Oncol Lett; 2021 May; 21(5):418. PubMed ID: 33841579
[TBL] [Abstract][Full Text] [Related]
2. Klotho expression is correlated to molecules associated with epithelial-mesenchymal transition in lung squamous cell carcinoma.
Ibi T; Usuda J; Inoue T; Sato A; Takegahara K
Oncol Lett; 2017 Nov; 14(5):5526-5532. PubMed ID: 29142604
[TBL] [Abstract][Full Text] [Related]
3. Overexpression of SLFN5 induced the epithelial-mesenchymal transition in human lung cancer cell line A549 through β-catenin/Snail/E-cadherin pathway.
Guo L; Liu Z; Tang X
Eur J Pharmacol; 2019 Nov; 862():172630. PubMed ID: 31472120
[TBL] [Abstract][Full Text] [Related]
4. Resolvin D1 inhibits TGF-β1-induced epithelial mesenchymal transition of A549 lung cancer cells via lipoxin A4 receptor/formyl peptide receptor 2 and GPR32.
Lee HJ; Park MK; Lee EJ; Lee CH
Int J Biochem Cell Biol; 2013 Dec; 45(12):2801-7. PubMed ID: 24120851
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of lung cancer cells growth, motility and induction of apoptosis by Klotho, a novel secreted Wnt antagonist, in a dose-dependent manner.
Chen B; Ma X; Liu S; Zhao W; Wu J
Cancer Biol Ther; 2012 Oct; 13(12):1221-8. PubMed ID: 22922788
[TBL] [Abstract][Full Text] [Related]
6. Transglutaminase-2 induces N-cadherin expression in TGF-β1-induced epithelial mesenchymal transition via c-Jun-N-terminal kinase activation by protein phosphatase 2A down-regulation.
Park MK; You HJ; Lee HJ; Kang JH; Oh SH; Kim SY; Lee CH
Eur J Cancer; 2013 May; 49(7):1692-705. PubMed ID: 23290789
[TBL] [Abstract][Full Text] [Related]
7. The ERK-ZEB1 pathway mediates epithelial-mesenchymal transition in pemetrexed resistant lung cancer cells with suppression by vinca alkaloids.
Chiu LY; Hsin IL; Yang TY; Sung WW; Chi JY; Chang JT; Ko JL; Sheu GT
Oncogene; 2017 Jan; 36(2):242-253. PubMed ID: 27270426
[TBL] [Abstract][Full Text] [Related]
8. BMI1-Mediated Pemetrexed Resistance in Non-Small Cell Lung Cancer Cells Is Associated with Increased SP1 Activation and Cancer Stemness.
Shen HT; Chien PJ; Chen SH; Sheu GT; Jan MS; Wang BY; Chang WW
Cancers (Basel); 2020 Jul; 12(8):. PubMed ID: 32726929
[TBL] [Abstract][Full Text] [Related]
9. Protein interaction networks characterizing the A549 cells Klotho transfected are associated with activated pro-apoptotic Bim and suppressed Wnt/β-catenin signaling pathway.
Matsumoto M; Ogawa N; Fukuda T; Bando Y; Nishimura T; Usuda J
Sci Rep; 2024 Jan; 14(1):2130. PubMed ID: 38267588
[TBL] [Abstract][Full Text] [Related]
10. Rab8 GTPase regulates Klotho-mediated inhibition of cell growth and progression by directly modulating its surface expression in human non-small cell lung cancer.
Chen B; Huang S; Pisanic Ii TR; Stark A; Tao Y; Cheng B; Li Y; Wei Y; Zhao W; Wang TH; Wu J
EBioMedicine; 2019 Nov; 49():118-132. PubMed ID: 31707148
[TBL] [Abstract][Full Text] [Related]
11. Regulation of epithelial mesenchymal transition by the renin-angiotensin system: a role for klotho in renal tubular epithelial cells.
Yang Z; Zhan YW; Huang YY; Huang W; Zhan F; Lin SD
J Biol Regul Homeost Agents; 2020; 34(1):57-67. PubMed ID: 32466632
[TBL] [Abstract][Full Text] [Related]
12. Epigenetic induction of epithelial to mesenchymal transition by LCN2 mediates metastasis and tumorigenesis, which is abrogated by NF-κB inhibitor BRM270 in a xenograft model of lung adenocarcinoma.
Mongre RK; Sodhi SS; Sharma N; Ghosh M; Kim JH; Kim N; Park YH; Shin YG; Kim SJ; Jiao ZJ; Huynh do L; Jeong DK
Int J Oncol; 2016 Jan; 48(1):84-98. PubMed ID: 26573874
[TBL] [Abstract][Full Text] [Related]
13. Overexpression of Napsin A resensitizes drug-resistant lung cancer A549 cells to gefitinib by inhibiting EMT.
Zhou L; Lv X; Yang J; Zhu Y; Wang Z; Xu T
Oncol Lett; 2018 Aug; 16(2):2533-2538. PubMed ID: 30008942
[TBL] [Abstract][Full Text] [Related]
14. BTBD7 Downregulates E-Cadherin and Promotes Epithelial-Mesenchymal Transition in Lung Cancer.
Shu J; Wang L; Han F; Chen Y; Wang S; Luo F
Biomed Res Int; 2019; 2019():5937635. PubMed ID: 31886230
[TBL] [Abstract][Full Text] [Related]
15. CNTN-1 Enhances Chemoresistance in Human Lung Adenocarcinoma Through Induction of Epithelial-Mesenchymal Transition by Targeting the PI3K/Akt Pathway.
Zhang R; Sun S; Ji F; Liu C; Lin H; Xie L; Yang H; Tang W; Zhou Y; Xu J; Li P
Cell Physiol Biochem; 2017; 43(2):465-480. PubMed ID: 28934754
[TBL] [Abstract][Full Text] [Related]
16. SPARC acts as a mediator of TGF-β1 in promoting epithelial-to-mesenchymal transition in A549 and H1299 lung cancer cells.
Sun W; Feng J; Yi Q; Xu X; Chen Y; Tang L
Biofactors; 2018 Sep; 44(5):453-464. PubMed ID: 30346081
[TBL] [Abstract][Full Text] [Related]
17. Genetic determinants of pemetrexed responsiveness and nonresponsiveness in non-small cell lung cancer cells.
Wu MF; Hsiao YM; Huang CF; Huang YH; Yang WJ; Chan HW; Chang JT; Ko JL
J Thorac Oncol; 2010 Aug; 5(8):1143-51. PubMed ID: 20559153
[TBL] [Abstract][Full Text] [Related]
18. TLE1 promotes EMT in A549 lung cancer cells through suppression of E-cadherin.
Yao X; Ireland SK; Pham T; Temple B; Chen R; Raj MH; Biliran H
Biochem Biophys Res Commun; 2014 Dec; 455(3-4):277-84. PubMed ID: 25446087
[TBL] [Abstract][Full Text] [Related]
19. Overexpression of lncRNA HOXA11-AS promotes cell epithelial-mesenchymal transition by repressing miR-200b in non-small cell lung cancer.
Chen JH; Zhou LY; Xu S; Zheng YL; Wan YF; Hu CP
Cancer Cell Int; 2017; 17():64. PubMed ID: 28615992
[TBL] [Abstract][Full Text] [Related]
20. Geraniin inhibits TGF-β1-induced epithelial-mesenchymal transition and suppresses A549 lung cancer migration, invasion and anoikis resistance.
Ko H
Bioorg Med Chem Lett; 2015 Sep; 25(17):3529-34. PubMed ID: 26169124
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
